Iron-sulfur cluster biogenesis in mammalian cells: New insights into the molecular mechanisms of cluster delivery

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 6, 2015, Pages 1493-1512

  Maio, Nunziata ^a   Rouault, Tracey A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

HSC20; HSPA9; ISCU; LYR motif protein; Mammalian fe S cluster assembly; SDHB

Indexed keywords

HEAT SHOCK PROTEIN 70; HSPA9 PROTEIN, HUMAN; IRON; IRON SULFUR PROTEIN; MITOCHONDRIAL PROTEIN; SULFUR;

AMINO ACID SEQUENCE; BIOSYNTHESIS; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; MOLECULAR GENETICS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; BIOSYNTHETIC PATHWAYS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IRON; IRON-SULFUR PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; SULFUR;

EID: 84930051032     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.09.009     Document Type: Review

References (330)

1. Arnon D.I., Whatley F.R., Allen M.B. Triphosphopyridine nucleotide as a catalyst of photosynthetic phosphorylation. Nature 1957, 180:182-185.
2. Mortenson L.E., Valentine R.C., Carnahan J.E. An electron transport factor from Clostridium pasteurianum. Biochem. Biophys. Res. Commun. 1962, 7:448-452.
3. Lovenberg W. Iron-Sulfur Proteins 1973, Academic Press, New York.
4. Beinert H., Sands R.H. Studies on succinic and DPNH dehydrogenase preparations by paramagnetic resonance (EPR) spectroscopy. Biochem. Biophys. Res. Commun. 1960, 3:41-46.
5. Malkin R., Rabinowitz J.C. The reconstitution of clostridial ferredoxin. Biochem. Biophys. Res. Commun. 1966, 23:822-827.
6. Beinert H., Holm R.H., Munck E. Iron-sulfur clusters: nature's modular, multipurpose structures. Science 1997, 277:653-659.
7. Martin W., Baross J., Kelley D., Russell M.J. Hydrothermal vents and the origin of life. Nat. Rev. 2008, 6:805-814.
8. Russell M.J., Martin W. The rocky roots of the acetyl-CoA pathway. Trends Biochem. Sci. 2004, 29:358-363.
9. Imlay J.A. Iron-sulphur clusters and the problem with oxygen. Mol. Microbiol. 2006, 59:1073-1082.
10. Giel J.L., Nesbit A.D., Mettert E.L., Fleischhacker A.S., Wanta B.T., Kiley P.J. Regulation of iron-sulphur cluster homeostasis through transcriptional control of the Isc pathway by [2Fe-2S]-IscR in Escherichia coli. Mol. Microbiol. 2012, 87:478-492.
11. Zhang B., Crack J.C., Subramanian S., Green J., Thomson A.J., Le Brun N.E., Johnson M.K. Reversible cycling between cysteine persulfide-ligated [2Fe-2S] and cysteine-ligated [4Fe-4S] clusters in the FNR regulatory protein. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:15734-15739.
12. Rouault T.A. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat. Chem. Biol. 2006, 2:406-414.
13. Volz K. The functional duality of iron regulatory protein 1. Curr. Opin. Struct. Biol. 2008, 18:106-111.
14. Hentze M.W., Muckenthaler M.U., Galy B., Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell 2010, 142:24-38.
15. White M.F., Dillingham M.S. Iron-sulphur clusters in nucleic acid processing enzymes. Curr. Opin. Struct. Biol. 2012, 22:94-100.
16. Netz D.J., Stith C.M., Stumpfig M., Kopf G., Vogel D., Genau H.M., Stodola J.L., Lill R., Burgers P.M., Pierik A.J. Eukaryotic DNA polymerases require an iron-sulfur cluster for the formation of active complexes. Nat. Chem. Biol. 2012, 8:125-132.
17. Rudolf J., Makrantoni V., Ingledew W.J., Stark M.J., White M.F. The DNA repair helicases XPD and FancJ have essential iron-sulfur domains. Mol. Cell 2006, 23:801-808.
18. Kispal G., Sipos K., Lange H., Fekete Z., Bedekovics T., Janaky T., Bassler J., Aguilar Netz D.J., Balk J., Rotte C., Lill R. Biogenesis of cytosolic ribosomes requires the essential iron-sulphur protein Rli1p and mitochondria. EMBO J. 2005, 24:589-598.
19. Yarunin A., Panse V.G., Petfalski E., Dez C., Tollervey D., Hurt E.C. Functional link between ribosome formation and biogenesis of iron-sulfur proteins. EMBO J. 2005, 24:580-588.
20. Dong J., Lai R., Nielsen K., Fekete C.A., Qiu H., Hinnebusch A.G. The essential ATP-binding cassette protein RLI1 functions in translation by promoting preinitiation complex assembly. J. Biol. Chem. 2004, 279:42157-42168.
21. Chen Z.Q., Dong J., Ishimura A., Daar I., Hinnebusch A.G., Dean M. The essential vertebrate ABCE1 protein interacts with eukaryotic initiation factors. J. Biol. Chem. 2006, 281:7452-7457.
22. Khoshnevis S., Gross T., Rotte C., Baierlein C., Ficner R., Krebber H. The iron-sulphur protein RNase L inhibitor functions in translation termination. EMBO Rep. 2010, 11:214-219.
23. Shoemaker C.J., Green R. Kinetic analysis reveals the ordered coupling of translation termination and ribosome recycling in yeast. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:E1392-E1398.
24. Barthelme D., Scheele U., Dinkelaker S., Janoschka A., Macmillan F., Albers S.V., Driessen A.J., Stagni M.S., Bill E., Meyer-Klaucke W., Schunemann V., Tampe R. Structural organization of essential iron-sulfur clusters in the evolutionarily highly conserved ATP-binding cassette protein ABCE1. J. Biol. Chem. 2007, 282:14598-14607.
25. Lanz N.D., Booker S.J. Identification and function of auxiliary iron-sulfur clusters in radical SAM enzymes. Biochim. Biophys. Acta 2012, 1824:1196-1212.
26. Ollagnier-De Choudens S., Sanakis Y., Hewitson K.S., Roach P., Baldwin J.E., Munck E., Fontecave M. Iron-sulfur center of biotin synthase and lipoate synthase. Biochemistry 2000, 39:4165-4173.
27. Frazzon J., Dean D.R. Formation of iron-sulfur clusters in bacteria: an emerging field in bioinorganic chemistry. Curr. Opin. Chem. Biol. 2003, 7:166-173.
28. Roche B., Aussel L., Ezraty B., Mandin P., Py B., Barras F. Iron/sulfur proteins biogenesis in prokaryotes: formation, regulation and diversity. Biochim. Biophys. Acta 2013, 1827:455-469.
29. Couturier J., Touraine B., Briat J.F., Gaymard F., Rouhier N. The iron-sulfur cluster assembly machineries in plants: current knowledge and open questions. Front. Plant Sci. 2013, 4:259.
30. Rouault T.A. Biogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease. Dis. Model. Mech. 2012, 5:155-164.
31. Stehling O., Wilbrecht C., Lill R. Mitochondrial iron-sulfur protein biogenesis and human disease. Biochimie 2014, 100:61-77.
32. Shi Y., Ghosh M., Kovtunovych G., Crooks D.R., Rouault T.A. Both human ferredoxins 1 and 2 and ferredoxin reductase are important for iron-sulfur cluster biogenesis. Biochim. Biophys. Acta 2012, 1823:484-492.
33. Kim J.H., Frederick R.O., Reinen N.M., Troupis A.T., Markley J.L. [2Fe-2S]-ferredoxin binds directly to cysteine desulfurase and supplies an electron for iron-sulfur cluster assembly but is displaced by the scaffold protein or bacterial frataxin. J. Am. Chem. Soc. 2013, 135:8117-8120.
34. Vickery L.E., Cupp-Vickery J.R. Molecular chaperones HscA/Ssq1 and HscB/Jac1 and their roles in iron-sulfur protein maturation. Crit. Rev. Biochem. Mol. Biol. 2007, 42:95-111.
35. Pukszta S., Schilke B., Dutkiewicz R., Kominek J., Moczulska K., Stepien B., Reitenga K.G., Bujnicki J.M., Williams B., Craig E.A., Marszalek J. Co-evolution-driven switch of J-protein specificity towards an Hsp70 partner. EMBO Rep. 2010, 11:360-365.
36. Ajit Bolar N., Vanlander A.V., Wilbrecht C., Van der Aa N., Smet J., De Paepe B., Vandeweyer G., Kooy F., Eyskens F., De Latter E., Delanghe G., Govaert P., Leroy J.G., Loeys B., Lill R., Van Laer L., Van Coster R. Mutation of the iron-sulfur cluster assembly gene IBA57 causes severe myopathy and encephalopathy. Hum. Mol. Genet. 2013, 22:2590-2602.
37. Maio N., Singh A., Uhrigshardt H., Saxena N., Tong W.H., Rouault T.A. Cochaperone binding to LYR motifs confers specificity of iron sulfur cluster delivery. Cell Metab. 2014, 19:445-457.
38. Johnson D.C., Dean D.R., Smith A.D., Johnson M.K. Structure, function, and formation of biological iron-sulfur clusters. Annu. Rev. Biochem. 2005, 74:247-281.
39. Selbach B.P., Pradhan P.K., Dos Santos P.C. Protected sulfur transfer reactions by the Escherichia coli Suf system. Biochemistry 2013, 52:4089-4096.
40. Barras F., Loiseau L., Py B. How Escherichia coli and Saccharomyces cerevisiae build Fe/S proteins. Adv. Microb. Physiol. 2005, 50:41-101.
41. Muhlenhoff U., Gerber J., Richhardt N., Lill R. Components involved in assembly and dislocation of iron-sulfur clusters on the scaffold protein Isu1p. EMBO J. 2003, 22:4815-4825.
42. Xu X.M., Adams S., Chua N.H., Moller S.G. AtNAP1 represents an atypical SufB protein in Arabidopsis plastids. J. Biol. Chem. 2005, 280:6648-6654.
43. Shi R., Proteau A., Villarroya M., Moukadiri I., Zhang L., Trempe J.F., Matte A., Armengod M.E., Cygler M. Structural basis for Fe-S cluster assembly and tRNA thiolation mediated by IscS protein-protein interactions. PLoS Biol. 2010, 8:e1000354.
44. Colin F., Martelli A., Clemancey M., Latour J.M., Gambarelli S., Zeppieri L., Birck C., Page A., Puccio H., Ollagnier de Choudens S. Mammalian frataxin controls sulfur production and iron entry during de novo Fe4S4 cluster assembly. J. Am. Chem. Soc. 2013, 135:733-740.
45. Schmucker S., Martelli A., Colin F., Page A., Wattenhofer-Donze M., Reutenauer L., Puccio H. Mammalian frataxin: an essential function for cellular viability through an interaction with a preformed ISCU/NFS1/ISD11 iron-sulfur assembly complex. PLoS One 2011, 6:e16199.
46. Pandey A., Golla R., Yoon H., Dancis A., Pain D. Persulfide formation on mitochondrial cysteine desulfurase: enzyme activation by a eukaryote-specific interacting protein and Fe-S cluster synthesis. Biochem. J. 2012, 448:171-187.
47. Adam A.C., Bornhovd C., Prokisch H., Neupert W., Hell K. The Nfs1 interacting protein Isd11 has an essential role in Fe/S cluster biogenesis in mitochondria. EMBO J. 2006, 25:174-183.
48. Terali K., Beavil R.L., Pickersgill R.W., van der Giezen M. The effect of the adaptor protein Isd11 on the quaternary structure of the eukaryotic cysteine desulphurase Nfs1. Biochem. Biophys. Res. Commun. 2013, 440:235-240.
49. Lim S.C., Friemel M., Marum J.E., Tucker E.J., Bruno D.L., Riley L.G., Christodoulou J., Kirk E.P., Boneh A., DeGennaro C.M., Springer M., Mootha V.K., Rouault T.A., Leimkuhler S., Thorburn D.R., Compton A.G. Mutations in LYRM4, encoding iron-sulfur cluster biogenesis factor ISD11, cause deficiency of multiple respiratory chain complexes. Hum. Mol. Genet. 2013, 22:4460-4473.
50. Shi Y., Ghosh M.C., Tong W.H., Rouault T.A. Human ISD11 is essential for both iron-sulfur cluster assembly and maintenance of normal cellular iron homeostasis. Hum. Mol. Genet. 2009, 18:3014-3025.
51. Land T., Rouault T.A. Targeting of a human iron-sulfur cluster assembly enzyme, nifs, to different subcellular compartments is regulated through alternative AUG utilization. Mol. Cell 1998, 2:807-815.
52. Tong W.H., Rouault T. Distinct iron-sulfur cluster assembly complexes exist in the cytosol and mitochondria of human cells. EMBO J. 2000, 19:5692-5700.
53. Tong W.H., Jameson G.N., Huynh B.H., Rouault T.A. Subcellular compartmentalization of human Nfu, an iron-sulfur cluster scaffold protein, and its ability to assemble a [4Fe-4S] cluster. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:9762-9767.
54. Tong W.H., Rouault T.A. Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-sulfur cluster biogenesis and iron homeostasis. Cell Metab. 2006, 3:199-210.
55. Stemmler T.L., Lesuisse E., Pain D., Dancis A. Frataxin and mitochondrial FeS cluster biogenesis. J. Biol. Chem. 2010, 285:26737-26743.
56. Qi W., Cowan J.A. Mechanism of glutaredoxin-ISU [2Fe-2S] cluster exchange. Chem. Commun. (Camb.) 2011, 47:4989-4991.
57. Tsai C.L., Barondeau D.P. Human frataxin is an allosteric switch that activates the Fe-S cluster biosynthetic complex. Biochemistry 2010, 49:9132-9139.
58. Prischi F., Konarev P.V., Iannuzzi C., Pastore C., Adinolfi S., Martin S.R., Svergun D.I., Pastore A. Structural bases for the interaction of frataxin with the central components of iron-sulphur cluster assembly. Nat. Commun. 2010, 1:95.
59. Adinolfi S., Iannuzzi C., Prischi F., Pastore C., Iametti S., Martin S.R., Bonomi F., Pastore A. Bacterial frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS. Nat. Struct. Mol. Biol. 2009, 16:390-396.
60. Pandey A., Gordon D.M., Pain J., Stemmler T.L., Dancis A., Pain D. Frataxin directly stimulates mitochondrial cysteine desulfurase by exposing substrate-binding sites, and a mutant Fe-S cluster scaffold protein with frataxin-bypassing ability acts similarly. J. Biol. Chem. 2013, 288:36773-36786.
61. Wilson R.B., Roof D.M. Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue. Nat. Genet. 1997, 16:352-357.
62. Cavadini P., Gellera C., Patel P.I., Isaya G. Human frataxin maintains mitochondrial iron homeostasis in Saccharomyces cerevisiae. Hum. Mol. Genet. 2000, 9:2523-2530.
63. Sheftel A.D., Stehling O., Pierik A.J., Elsasser H.P., Muhlenhoff U., Webert H., Hobler A., Hannemann F., Bernhardt R., Lill R. Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe/S cluster biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11775-11780.
64. Chandramouli K., Unciuleac M.C., Naik S., Dean D.R., Huynh B.H., Johnson M.K. Formation and properties of [4Fe-4S] clusters on the IscU scaffold protein. Biochemistry 2007, 46:6804-6811.
65. Raulfs E.C., O'Carroll I.P., Dos Santos P.C., Unciuleac M.C., Dean D.R. In vivo iron-sulfur cluster formation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:8591-8596.
66. Marinoni E.N., de Oliveira J.S., Nicolet Y., Raulfs E.C., Amara P., Dean D.R., Fontecilla-Camps J.C. (IscS-IscU)2 complex structures provide insights into Fe2S2 biogenesis and transfer. Angew. Chem. Int. Ed. Engl. 2012, 51:5439-5442.
67. Hoff K.G., Silberg J.J., Vickery L.E. Interaction of the iron-sulfur cluster assembly protein IscU with the Hsc66/Hsc20 molecular chaperone system of Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:7790-7795.
68. Uhrigshardt H., Singh A., Kovtunovych G., Ghosh M., Rouault T.A. Characterization of the human HSC20, an unusual DnaJ type III protein, involved in iron-sulfur cluster biogenesis. Hum. Mol. Genet. 2010, 19:3816-3834.
69. Craig E.A., Marszalek J. A specialized mitochondrial molecular chaperone system: a role in formation of Fe/S centers. Cell. Mol. Life Sci. 2002, 59:1658-1665.
70. Shan Y., Cortopassi G. HSC20 interacts with frataxin and is involved in iron-sulfur cluster biogenesis and iron homeostasis. Hum. Mol. Genet. 2012, 21:1457-1469.
71. Cai K., Frederick R.O., Kim J.H., Reinen N.M., Tonelli M., Markley J.L. Human mitochondrial chaperone (mtHSP70) and cysteine desulfurase (NFS1) bind preferentially to the disordered conformation, whereas co-chaperone (HSC20) binds to the structured conformation of the iron-sulfur cluster scaffold protein (ISCU). J. Biol. Chem. 2013, 288:28755-28770.
72. Kampinga H.H., Craig E.A. The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nat. Rev. Mol. Cell Biol. 2010, 11:579-592.
73. Fuzery A.K., Tonelli M., Ta D.T., Cornilescu G., Vickery L.E., Markley J.L. Solution structure of the iron-sulfur cluster cochaperone HscB and its binding surface for the iron-sulfur assembly scaffold protein IscU. Biochemistry 2008, 47:9394-9404.
74. Ciesielski S.J., Schilke B.A., Osipiuk J., Bigelow L., Mulligan R., Majewska J., Joachimiak A., Marszalek J., Craig E.A., Dutkiewicz R. Interaction of J-protein co-chaperone Jac1 with Fe-S scaffold Isu is indispensable in vivo and conserved in evolution. J. Mol. Biol. 2012, 417:1-12.
75. Fuzery A.K., Oh J.J., Ta D.T., Vickery L.E., Markley J.L. Three hydrophobic amino acids in Escherichia coli HscB make the greatest contribution to the stability of the HscB-IscU complex. BMC Biochem. 2011, 12:3.
76. Cupp-Vickery J.R., Vickery L.E. Crystal structure of Hsc20, a J-type co-chaperone from Escherichia coli. J. Mol. Biol. 2000, 304:835-845.
77. Bitto E., Bingman C.A., Bittova L., Kondrashov D.A., Bannen R.M., Fox B.G., Markley J.L., Phillips G.N. Structure of human J-type co-chaperone HscB reveals a tetracysteine metal-binding domain. J. Biol. Chem. 2008, 283:30184-30192.
78. Knieszner H., Schilke B., Dutkiewicz R., D'Silva P., Cheng S., Ohlson M., Craig E.A., Marszalek J. Compensation for a defective interaction of the hsp70 ssq1 with the mitochondrial Fe-S cluster scaffold isu. J. Biol. Chem. 2005, 280:28966-28972.
79. Voisine C., Cheng Y.C., Ohlson M., Schilke B., Hoff K., Beinert H., Marszalek J., Craig E.A. Jac1, a mitochondrial J-type chaperone, is involved in the biogenesis of Fe/S clusters in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:1483-1488.
80. Majewska J., Ciesielski S.J., Schilke B., Kominek J., Blenska A., Delewski W., Song J.Y., Marszalek J., Craig E.A., Dutkiewicz R. Binding of the chaperone Jac1 protein and cysteine desulfurase Nfs1 to the iron-sulfur cluster scaffold Isu protein is mutually exclusive. J. Biol. Chem. 2013, 288:29134-29142.
81. Bonomi F., Iametti S., Morleo A., Ta D., Vickery L.E. Facilitated transfer of IscU-[2Fe2S] clusters by chaperone-mediated ligand exchange. Biochemistry 2011, 50:9641-9650.
82. Dutkiewicz R., Schilke B., Cheng S., Knieszner H., Craig E.A., Marszalek J. Sequence-specific interaction between mitochondrial Fe-S scaffold protein Isu and Hsp70 Ssq1 is essential for their in vivo function. J. Biol. Chem. 2004, 279:29167-29174.
83. Cupp-Vickery J.R., Peterson J.C., Ta D.T., Vickery L.E. Crystal structure of the molecular chaperone HscA substrate binding domain complexed with the IscU recognition peptide ELPPVKIHC. J. Mol. Biol. 2004, 342:1265-1278.
84. Wadhwa R., Taira K., Kaul S.C. An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?. Cell Stress Chaperones 2002, 7:309-316.
85. Daugaard M., Rohde M., Jaattela M. The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions. FEBS Lett. 2007, 581:3702-3710.
86. Szabo A., Korszun R., Hartl F.U., Flanagan J. A zinc finger-like domain of the molecular chaperone DnaJ is involved in binding to denatured protein substrates. EMBO J. 1996, 15:408-417.
87. Perales-Calvo J., Muga A., Moro F. Role of DnaJ G/F-rich domain in conformational recognition and binding of protein substrates. J. Biol. Chem. 2010, 285:34231-34239.
88. Li J., Sha B. Structure-based mutagenesis studies of the peptide substrate binding fragment of type I heat-shock protein 40. Biochem. J. 2005, 386:453-460.
89. Lee S., Fan C.Y., Younger J.M., Ren H., Cyr D.M. Identification of essential residues in the type II Hsp40 Sis1 that function in polypeptide binding. J. Biol. Chem. 2002, 277:21675-21682.
90. Kim R., Saxena S., Gordon D.M., Pain D., Dancis A. J-domain protein, Jac1p, of yeast mitochondria required for iron homeostasis and activity of Fe-S cluster proteins. J. Biol. Chem. 2001, 276:17524-17532.
91. Uhrigshardt H., Rouault T.A., Missirlis F. Insertion mutants in Drosophila melanogaster Hsc20 halt larval growth and lead to reduced iron-sulfur cluster enzyme activities and impaired iron homeostasis. J. Biol. Inorg. Chem. 2013, 18:441-449.
92. Sanchez E., Lobo T., Fox J.L., Zeviani M., Winge D.R., Fernandez-Vizarra E. LYRM7/MZM1L is a UQCRFS1 chaperone involved in the last steps of mitochondrial Complex III assembly in human cells. Biochim. Biophys. Acta 2013, 1827:285-293.
93. Angerer H. The superfamily of mitochondrial Complex1_LYR motif-containing (LYRM) proteins. Biochem. Soc. Trans. 2013, 41:1335-1341.
94. Ghezzi D., Goffrini P., Uziel G., Horvath R., Klopstock T., Lochmuller H., D'Adamo P., Gasparini P., Strom T.M., Prokisch H., Invernizzi F., Ferrero I., Zeviani M. SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy. Nat. Genet. 2009, 41:654-656.
95. Dennis R.A., McCammon M.T. Acn9 is a novel protein of gluconeogenesis that is located in the mitochondrial intermembrane space. Eur. J. Biochem. 1999, 261:236-243.
96. Dick D.M., Aliev F., Wang J.C., Saccone S., Hinrichs A., Bertelsen S., Budde J., Saccone N., Foroud T., Nurnberger J., Xuei X., Conneally P.M., Schuckit M., Almasy L., Crowe R., Kuperman S., Kramer J., Tischfield J.A., Hesselbrock V., Edenberg H.J., Porjesz B., Rice J.P., Bierut L., Goate A. A systematic single nucleotide polymorphism screen to fine-map alcohol dependence genes on chromosome 7 identifies association with a novel susceptibility gene ACN9. Biol. Psychiatry 2008, 63:1047-1053.
97. Lefebvre-Legendre L., Vaillier J., Benabdelhak H., Velours J., Slonimski P.P., di Rago J.P. Identification of a nuclear gene (FMC1) required for the assembly/stability of yeast mitochondrial F(1)-ATPase in heat stress conditions. J. Biol. Chem. 2001, 276:6789-6796.
98. Punta M., Coggill P.C., Eberhardt R.Y., Mistry J., Tate J., Boursnell C., Pang N., Forslund K., Ceric G., Clements J., Heger A., Holm L., Sonnhammer E.L., Eddy S.R., Bateman A., Finn R.D. The Pfam protein families database. Nucleic Acids Res. 2012, 40:D290-D301.
99. Angerer H., Radermacher M., Malkowska M., Steger M., Zwicker K., Heide H., Wittig I., Brandt U., Zickermann V. The LYR protein subunit NB4M/NDUFA6 of mitochondrial complex I anchors an acyl carrier protein and is essential for catalytic activity. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:5207-5212.
100. Fassone E., Rahman S. Complex I deficiency: clinical features, biochemistry and molecular genetics. J. Med. Genet. 2012, 49:578-590.
101. Uzarska M.A., Dutkiewicz R., Freibert S.A., Lill R., Muhlenhoff U. The mitochondrial Hsp70 chaperone Ssq1 facilitates Fe/S cluster transfer from Isu1 to Grx5 by complex formation. Mol. Biol. Cell 2013, 24:1830-1841.
102. Rodriguez-Manzaneque M.T., Tamarit J., Belli G., Ros J., Herrero E. Grx5 is a mitochondrial glutaredoxin required for the activity of iron/sulfur enzymes. Mol. Biol. Cell 2002, 13:1109-1121.
103. Wingert R.A., Galloway J.L., Barut B., Foott H., Fraenkel P., Axe J.L., Weber G.J., Dooley K., Davidson A.J., Schmid B., Paw B.H., Shaw G.C., Kingsley P., Palis J., Schubert H., Chen O., Kaplan J., Zon L.I. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature 2005, 436:1035-1039.
104. Rouhier N., Couturier J., Johnson M.K., Jacquot J.P. Glutaredoxins: roles in iron homeostasis. Trends Biochem. Sci. 2010, 35:43-52.
105. Li H., Outten C.E. Monothiol CGFS glutaredoxins and BolA-like proteins: [2Fe-2S] binding partners in iron homeostasis. Biochemistry 2012, 51:4377-4389.
106. Lillig C.H., Berndt C., Holmgren A. Glutaredoxin systems. Biochim. Biophys. Acta 2008, 1780:1304-1317.
107. Lill R. Function and biogenesis of iron-sulphur proteins. Nature 2009, 460:831-838.
108. Ye H., Jeong S.Y., Ghosh M.C., Kovtunovych G., Silvestri L., Ortillo D., Uchida N., Tisdale J., Camaschella C., Rouault T.A. Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts. J. Clin. Invest. 2010, 120:1749-1761.
109. Camaschella C., Campanella A., De Falco L., Boschetto L., Merlini R., Silvestri L., Levi S., Iolascon A. The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood 2007, 110:1353-1358.
110. Ye H., Rouault T.A. Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease. Biochemistry 2010, 49:4945-4956.
111. Herrero E., Belli G., Casa C. Structural and functional diversity of glutaredoxins in yeast. Curr. Protein Pept. Sci. 2010, 11:659-668.
112. Dhalleine T., Rouhier N., Couturier J. Putative roles of glutaredoxin-BolA holo-heterodimers in plants. Plant Signal. Behav. 2014, 9.
113. Muhlenhoff U., Molik S., Godoy J.R., Uzarska M.A., Richter N., Seubert A., Zhang Y., Stubbe J., Pierrel F., Herrero E., Lillig C.H., Lill R. Cytosolic monothiol glutaredoxins function in intracellular iron sensing and trafficking via their bound iron-sulfur cluster. Cell Metab. 2010, 12:373-385.
114. Kumanovics A., Chen O.S., Li L., Bagley D., Adkins E.M., Lin H., Dingra N.N., Outten C.E., Keller G., Winge D., Ward D.M., Kaplan J. Identification of FRA1 and FRA2 as genes involved in regulating the yeast iron regulon in response to decreased mitochondrial iron-sulfur cluster synthesis. J. Biol. Chem. 2008, 283:10276-10286.
115. Ojeda L., Keller G., Muhlenhoff U., Rutherford J.C., Lill R., Winge D.R. Role of glutaredoxin-3 and glutaredoxin-4 in the iron regulation of the Aft1 transcriptional activator in Saccharomyces cerevisiae. J. Biol. Chem. 2006, 281:17661-17669.
116. Pujol-Carrion N., Belli G., Herrero E., Nogues A., de la Torre-Ruiz M.A. Glutaredoxins Grx3 and Grx4 regulate nuclear localisation of Aft1 and the oxidative stress response in Saccharomyces cerevisiae. J. Cell Sci. 2006, 119:4554-4564.
117. Iwema T., Picciocchi A., Traore D.A., Ferrer J.L., Chauvat F., Jacquamet L. Structural basis for delivery of the intact [Fe2S2] cluster by monothiol glutaredoxin. Biochemistry 2009, 48:6041-6043.
118. Johansson C., Roos A.K., Montano S.J., Sengupta R., Filippakopoulos P., Guo K., von Delft F., Holmgren A., Oppermann U., Kavanagh K.L. The crystal structure of human GLRX5: iron-sulfur cluster co-ordination, tetrameric assembly and monomer activity. Biochem. J. 2011, 433:303-311.
119. Qi W., Li J., Chain C.Y., Pasquevich G.A., Pasquevich A.F., Cowan J.A. Glutathione complexed Fe-S centers. J. Am. Chem. Soc. 2012, 134:10745-10748.
120. Shakamuri P., Zhang B., Johnson M.K. Monothiol glutaredoxins function in storing and transporting [Fe2S2] clusters assembled on IscU scaffold proteins. J. Am. Chem. Soc. 2012, 134:15213-15216.
121. Huynen M.A., Spronk C.A., Gabaldon T., Snel B. Combining data from genomes, Y2H and 3D structure indicates that BolA is a reductase interacting with a glutaredoxin. FEBS Lett. 2005, 579:591-596.
122. Couturier J., Jacquot J.P., Rouhier N. Evolution and diversity of glutaredoxins in photosynthetic organisms. Cell. Mol. Life Sci. 2009, 66:2539-2557.
123. Ito T., Chiba T., Ozawa R., Yoshida M., Hattori M., Sakaki Y. A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:4569-4574.
124. Giot L., Bader J.S., Brouwer C., Chaudhuri A., Kuang B., Li Y., Hao Y.L., Ooi C.E., Godwin B., Vitols E., Vijayadamodar G., Pochart P., Machineni H., Welsh M., Kong Y., Zerhusen B., Malcolm R., Varrone Z., Collis A., Minto M., Burgess S., McDaniel L., Stimpson E., Spriggs F., Williams J., Neurath K., Ioime N., Agee M., Voss E., Furtak K., Renzulli R., Aanensen N., Carrolla S., Bickelhaupt E., Lazovatsky Y., DaSilva A., Zhong J., Stanyon C.A., Finley R.L., White K.P., Braverman M., Jarvie T., Gold S., Leach M., Knight J., Shimkets R.A., McKenna M.P., Chant J., Rothberg J.M. A protein interaction map of Drosophila melanogaster. Science 2003, 302:1727-1736.
125. Couturier J., Wu H.C., Dhalleine T., Pegeot H., Sudre D., Gualberto J.M., Jacquot J.P., Gaymard F., Vignols F., Rouhier N. Monothiol glutaredoxin-BolA interactions: redox control of Arabidopsis thaliana BolA2 and SufE1. Mol. Plant 2014, 7:187-205.
126. Aldea M., Garrido T., Hernandez-Chico C., Vicente M., Kushner S.R. Induction of a growth-phase-dependent promoter triggers transcription of bolA, an Escherichia coli morphogene. EMBO J. 1989, 8:3923-3931.
127. Li H., Mapolelo D.T., Dingra N.N., Naik S.G., Lees N.S., Hoffman B.M., Riggs-Gelasco P.J., Huynh B.H., Johnson M.K., Outten C.E. The yeast iron regulatory proteins Grx3/4 and Fra2 form heterodimeric complexes containing a [2Fe-2S] cluster with cysteinyl and histidyl ligation. Biochemistry 2009, 48:9569-9581.
128. Li H., Mapolelo D.T., Dingra N.N., Keller G., Riggs-Gelasco P.J., Winge D.R., Johnson M.K., Outten C.E. Histidine 103 in Fra2 is an iron-sulfur cluster ligand in the [2Fe-2S] Fra2-Grx3 complex and is required for in vivo iron signaling in yeast. J. Biol. Chem. 2011, 286:867-876.
129. Yamaguchi-Iwai Y., Stearman R., Dancis A., Klausner R.D. Iron-regulated DNA binding by the AFT1 protein controls the iron regulon in yeast. EMBO J. 1996, 15:3377-3384.
130. Yamaguchi-Iwai Y., Ueta R., Fukunaka A., Sasaki R. Subcellular localization of Aft1 transcription factor responds to iron status in Saccharomyces cerevisiae. J. Biol. Chem. 2002, 277:18914-18918.
131. Casas C., Aldea M., Espinet C., Gallego C., Gil R., Herrero E. The AFT1 transcriptional factor is differentially required for expression of high-affinity iron uptake genes in Saccharomyces cerevisiae. Yeast 1997, 13:621-637.
132. Ueta R., Fujiwara N., Iwai K., Yamaguchi-Iwai Y. Mechanism underlying the iron-dependent nuclear export of the iron-responsive transcription factor Aft1p in Saccharomyces cerevisiae. Mol. Biol. Cell 2007, 18:2980-2990.
133. Cameron J.M., Janer A., Levandovskiy V., Mackay N., Rouault T.A., Tong W.H., Ogilvie I., Shoubridge E.A., Robinson B.H. Mutations in iron-sulfur cluster scaffold genes NFU1 and BOLA3 cause a fatal deficiency of multiple respiratory chain and 2-oxoacid dehydrogenase enzymes. Am. J. Hum. Genet. 2011, 89:486-495.
134. Haack T.B., Rolinski B., Haberberger B., Zimmermann F., Schum J., Strecker V., Graf E., Athing U., Hoppen T., Wittig I., Sperl W., Freisinger P., Mayr J.A., Strom T.M., Meitinger T., Prokisch H. Homozygous missense mutation in BOLA3 causes multiple mitochondrial dysfunctions syndrome in two siblings. J. Inherit. Metab. Dis. 2013, 36:55-62.
135. Navarro-Sastre A., Tort F., Stehling O., Uzarska M.A., Arranz J.A., Del Toro M., Labayru M.T., Landa J., Font A., Garcia-Villoria J., Merinero B., Ugarte M., Gutierrez-Solana L.G., Campistol J., Garcia-Cazorla A., Vaquerizo J., Riudor E., Briones P., Elpeleg O., Ribes A., Lill R. A fatal mitochondrial disease is associated with defective NFU1 function in the maturation of a subset of mitochondrial Fe-S proteins. Am. J. Hum. Genet. 2011, 89:656-667.
136. Ferrer-Cortes X., Font A., Bujan N., Navarro-Sastre A., Matalonga L., Arranz J.A., Riudor E., del Toro M., Garcia-Cazorla A., Campistol J., Briones P., Ribes A., Tort F. Protein expression profiles in patients carrying NFU1 mutations. Contribution to the pathophysiology of the disease. J. Inherit. Metab. Dis. 2013, 36:841-847.
137. Tan G., Lu J., Bitoun J.P., Huang H., Ding H. IscA/SufA paralogues are required for the [4Fe-4S] cluster assembly in enzymes of multiple physiological pathways in Escherichia coli under aerobic growth conditions. Biochem. J. 2009, 420:463-472.
138. Loiseau L., Gerez C., Bekker M., Ollagnier-de Choudens S., Py B., Sanakis Y., Teixeira de Mattos J., Fontecave M., Barras F. ErpA, an iron sulfur (Fe S) protein of the A-type essential for respiratory metabolism in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13626-13631.
139. Jensen L.T., Culotta V.C. Role of Saccharomyces cerevisiae ISA1 and ISA2 in iron homeostasis. Mol. Cell. Biol. 2000, 20:3918-3927.
140. Muhlenhoff U., Richter N., Pines O., Pierik A.J., Lill R. Specialized function of yeast Isa1 and Isa2 proteins in the maturation of mitochondrial [4Fe-4S] proteins. J. Biol. Chem. 2011, 286:41205-41216.
141. Gelling C., Dawes I.W., Richhardt N., Lill R., Muhlenhoff U. Mitochondrial Iba57p is required for Fe/S cluster formation on aconitase and activation of radical SAM enzymes. Mol. Cell. Biol. 2008, 28:1851-1861.
142. Muhlenhoff U., Gerl M.J., Flauger B., Pirner H.M., Balser S., Richhardt N., Lill R., Stolz J. The ISC [corrected] proteins Isa1 and Isa2 are required for the function but not for the de novo synthesis of the Fe/S clusters of biotin synthase in Saccharomyces cerevisiae. Eukaryot. Cell 2007, 6:495-504.
143. Sheftel A.D., Wilbrecht C., Stehling O., Niggemeyer B., Elsasser H.P., Muhlenhoff U., Lill R. The human mitochondrial ISCA1, ISCA2, and IBA57 proteins are required for [4Fe-4S] protein maturation. Mol. Biol. Cell 2012, 23:1157-1166.
144. Bych K., Kerscher S., Netz D.J., Pierik A.J., Zwicker K., Huynen M.A., Lill R., Brandt U., Balk J. The iron-sulphur protein Ind1 is required for effective complex I assembly. EMBO J. 2008, 27:1736-1746.
145. Sheftel A.D., Stehling O., Pierik A.J., Netz D.J., Kerscher S., Elsasser H.P., Wittig I., Balk J., Brandt U., Lill R. Human ind1, an iron-sulfur cluster assembly factor for respiratory complex I. Mol. Cell. Biol. 2009, 29:6059-6073.
146. Calvo S.E., Tucker E.J., Compton A.G., Kirby D.M., Crawford G., Burtt N.P., Rivas M., Guiducci C., Bruno D.L., Goldberger O.A., Redman M.C., Wiltshire E., Wilson C.J., Altshuler D., Gabriel S.B., Daly M.J., Thorburn D.R., Mootha V.K. High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency. Nat. Genet. 2010, 42:851-858.
147. Wydro M.M., Sharma P., Foster J.M., Bych K., Meyer E.H., Balk J. The evolutionarily conserved iron-sulfur protein INDH is required for complex I assembly and mitochondrial translation in Arabidopsis [corrected]. Plant Cell 2013, 25:4014-4027.
148. Li K., Tong W.H., Hughes R.M., Rouault T.A. Roles of the mammalian cytosolic cysteine desulfurase, ISCS, and scaffold protein, ISCU, in iron-sulfur cluster assembly. J. Biol. Chem. 2006, 281:12344-12351.
149. Netz D.J., Mascarenhas J., Stehling O., Pierik A.J., Lill R. Maturation of cytosolic and nuclear iron-sulfur proteins. Trends Cell Biol. 2014, 24:303-312.
150. Xu X.M., Lin H., Latijnhouwers M., Moller S.G. Dual localized AtHscB involved in iron sulfur protein biogenesis in Arabidopsis. PLoS One 2009, 4:e7662.
151. Mesecke N., Terziyska N., Kozany C., Baumann F., Neupert W., Hell K., Herrmann J.M. A disulfide relay system in the intermembrane space of mitochondria that mediates protein import. Cell 2005, 121:1059-1069.
152. Qi W., Li J., Cowan J.A. A structural model for glutathione-complexed iron-sulfur cluster as a substrate for ABCB7-type transporters. Chem. Commun. (Camb.) 2014, 50:3795-3798.
153. Kispal G., Csere P., Prohl C., Lill R. The mitochondrial proteins Atm1p and Nfs1p are essential for biogenesis of cytosolic Fe/S proteins. EMBO J. 1999, 18:3981-3989.
154. Cavadini P., Biasiotto G., Poli M., Levi S., Verardi R., Zanella I., Derosas M., Ingrassia R., Corrado M., Arosio P. RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload. Blood 2007, 109:3552-3559.
155. Netz D.J., Pierik A.J., Stumpfig M., Muhlenhoff U., Lill R. The Cfd1-Nbp35 complex acts as a scaffold for iron-sulfur protein assembly in the yeast cytosol. Nat. Chem. Biol. 2007, 3:278-286.
156. Netz D.J., Stumpfig M., Dore C., Muhlenhoff U., Pierik A.J., Lill R. Tah18 transfers electrons to Dre2 in cytosolic iron-sulfur protein biogenesis. Nat. Chem. Biol. 2010, 6:758-765.
157. Balk J., Pierik A.J., Netz D.J., Muhlenhoff U., Lill R. The hydrogenase-like Nar1p is essential for maturation of cytosolic and nuclear iron-sulphur proteins. EMBO J. 2004, 23:2105-2115.
158. Balk J., Aguilar Netz D.J., Tepper K., Pierik A.J., Lill R. The essential WD40 protein Cia1 is involved in a late step of cytosolic and nuclear iron-sulfur protein assembly. Mol. Cell. Biol. 2005, 25:10833-10841.
159. Stehling O., Vashisht A.A., Mascarenhas J., Jonsson Z.O., Sharma T., Netz D.J., Pierik A.J., Wohlschlegel J.A., Lill R. MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity. Science 2012, 337:195-199.
160. Gari K., Leon Ortiz A.M., Borel V., Flynn H., Skehel J.M., Boulton S.J. MMS19 links cytoplasmic iron-sulfur cluster assembly to DNA metabolism. Science 2012, 337:243-245.
161. Stehling O., Mascarenhas J., Vashisht A.A., Sheftel A.D., Niggemeyer B., Rosser R., Pierik A.J., Wohlschlegel J.A., Lill R. Human CIA2A-FAM96A and CIA2B-FAM96B integrate iron homeostasis and maturation of different subsets of cytosolic-nuclear iron-sulfur proteins. Cell Metab. 2013, 18:187-198.
162. Moroishi T., Nishiyama M., Takeda Y., Iwai K., Nakayama K.I. The FBXL5-IRP2 axis is integral to control of iron metabolism in vivo. Cell Metab. 2011, 14:339-351.
163. Ruiz J.C., Walker S.D., Anderson S.A., Eisenstein R.S., Bruick R.K. F-box and leucine-rich repeat protein 5 (FBXL5) is required for maintenance of cellular and systemic iron homeostasis. J. Biol. Chem. 2013, 288:552-560.
164. Campuzano V., Montermini L., Molto M.D., Pianese L., Cossee M., Cavalcanti F., Monros E., Rodius F., Duclos F., Monticelli A., Zara F., Canizares J., Koutnikova H., Bidichandani S.I., Gellera C., Brice A., Trouillas P., De Michele G., Filla A., De Frutos R., Palau F., Patel P.I., Di Donato S., Mandel J.L., Cocozza S., Koenig M., Pandolfo M. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996, 271:1423-1427.
165. Cossee M., Durr A., Schmitt M., Dahl N., Trouillas P., Allinson P., Kostrzewa M., Nivelon-Chevallier A., Gustavson K.H., Kohlschutter A., Muller U., Mandel J.L., Brice A., Koenig M., Cavalcanti F., Tammaro A., De Michele G., Filla A., Cocozza S., Labuda M., Montermini L., Poirier J., Pandolfo M. Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes. Ann. Neurol. 1999, 45:200-206.
166. Gellera C., Castellotti B., Mariotti C., Mineri R., Seveso V., Didonato S., Taroni F. Frataxin gene point mutations in Italian Friedreich ataxia patients. Neurogenetics 2007, 8:289-299.
167. Evans-Galea M.V., Corben L.A., Hasell J., Galea C.A., Fahey M.C., du Sart D., Delatycki M.B. A novel deletion-insertion mutation identified in exon 3 of FXN in two siblings with a severe Friedreich ataxia phenotype. Neurogenetics 2011, 12:307-313.
168. Zuhlke C.H., Dalski A., Habeck M., Straube K., Hedrich K., Hoeltzenbein M., Konstanzer A., Hellenbroich Y., Schwinger E. Extension of the mutation spectrum in Friedreich's ataxia: detection of an exon deletion and novel missense mutations. Eur. J. Hum. Genet. 2004, 12:979-982.
169. Anheim M., Mariani L.L., Calvas P., Cheuret E., Zagnoli F., Odent S., Seguela C., Marelli C., Fritsch M., Delaunoy J.P., Brice A., Durr A., Koenig M. Exonic deletions of FXN and early-onset Friedreich ataxia. Arch. Neurol. 2012, 69:912-916.
170. Schols L., Amoiridis G., Przuntek H., Frank G., Epplen J.T., Epplen C. Friedreich's ataxia. Revision of the phenotype according to molecular genetics. Brain 1997, 120(Pt 12):2131-2140.
171. Cossee M., Schmitt M., Campuzano V., Reutenauer L., Moutou C., Mandel J.L., Koenig M. Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:7452-7457.
172. Pandolfo M. Friedreich ataxia. Arch. Neurol. 2008, 65:1296-1303.
173. Sharma R., De Biase I., Gomez M., Delatycki M.B., Ashizawa T., Bidichandani S.I. Friedreich ataxia in carriers of unstable borderline GAA triplet-repeat alleles. Ann. Neurol. 2004, 56:898-901.
174. Filla A., De Michele G., Cavalcanti F., Pianese L., Monticelli A., Campanella G., Cocozza S. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am. J. Hum. Genet. 1996, 59:554-560.
175. Durr A., Cossee M., Agid Y., Campuzano V., Mignard C., Penet C., Mandel J.L., Brice A., Koenig M. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N. Engl. J. Med. 1996, 335:1169-1175.
176. Saveliev A., Everett C., Sharpe T., Webster Z., Festenstein R. DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing. Nature 2003, 422:909-913.
177. Martelli A., Napierala M., Puccio H. Understanding the genetic and molecular pathogenesis of Friedreich's ataxia through animal and cellular models. Dis. Model. Mech. 2012, 5:165-176.
178. Campuzano V., Montermini L., Lutz Y., Cova L., Hindelang C., Jiralerspong S., Trottier Y., Kish S.J., Faucheux B., Trouillas P., Authier F.J., Durr A., Mandel J.L., Vescovi A., Pandolfo M., Koenig M. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum. Mol. Genet. 1997, 6:1771-1780.
179. Groh M., Lufino M.M., Wade-Martins R., Gromak N. R-loops associated with triplet repeat expansions promote gene silencing in Friedreich ataxia and fragile X syndrome. PLoS Genet. 2014, 10:e1004318.
180. Bidichandani S.I., Ashizawa T., Patel P.I. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am. J. Hum. Genet. 1998, 62:111-121.
181. Martelli A., Wattenhofer-Donze M., Schmucker S., Bouvet S., Reutenauer L., Puccio H. Frataxin is essential for extramitochondrial Fe-S cluster proteins in mammalian tissues. Hum. Mol. Genet. 2007, 16:2651-2658.
182. Pandolfo M., Pastore A. The pathogenesis of Friedreich ataxia and the structure and function of frataxin. J. Neurol. 2009, 256(Suppl. 1):9-17.
183. Harding A.E., Hewer R.L. The heart disease of Friedreich's ataxia: a clinical and electrocardiographic study of 115 patients, with an analysis of serial electrocardiographic changes in 30 cases. Q. J. Med. 1983, 52:489-502.
184. Harding A.E. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 1981, 104:589-620.
185. Weidemann F., Rummey C., Bijnens B., Stork S., Jasaityte R., Dhooge J., Baltabaeva A., Sutherland G., Schulz J.B., Meier T. The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptoms. Circulation 2012, 125:1626-1634.
186. Rotig A., de Lonlay P., Chretien D., Foury F., Koenig M., Sidi D., Munnich A., Rustin P. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat. Genet. 1997, 17:215-217.
187. Bradley J.L., Blake J.C., Chamberlain S., Thomas P.K., Cooper J.M., Schapira A.H. Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum. Mol. Genet. 2000, 9:275-282.
188. Waldvogel D., van Gelderen P., Hallett M. Increased iron in the dentate nucleus of patients with Friedrich's ataxia. Ann. Neurol. 1999, 46:123-125.
189. Foury F., Cazzalini O. Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria. FEBS Lett. 1997, 411:373-377.
190. Lamarche J.B., Cote M., Lemieux B. The cardiomyopathy of Friedreich's ataxia morphological observations in 3 cases. Can. J. Neurol. Sci. 1980, 7:389-396.
191. Emond M., Lepage G., Vanasse M., Pandolfo M. Increased levels of plasma malondialdehyde in Friedreich ataxia. Neurology 2000, 55:1752-1753.
192. Schulz J.B., Dehmer T., Schols L., Mende H., Hardt C., Vorgerd M., Burk K., Matson W., Dichgans J., Beal M.F., Bogdanov M.B. Oxidative stress in patients with Friedreich ataxia. Neurology 2000, 55:1719-1721.
193. Wong A., Yang J., Cavadini P., Gellera C., Lonnerdal B., Taroni F., Cortopassi G. The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum. Mol. Genet. 1999, 8:425-430.
194. Willis J.H., Isaya G., Gakh O., Capaldi R.A., Marusich M.F. Lateral-flow immunoassay for the frataxin protein in Friedreich's ataxia patients and carriers. Mol. Genet. Metab. 2008, 94:491-497.
195. Cossee M., Puccio H., Gansmuller A., Koutnikova H., Dierich A., LeMeur M., Fischbeck K., Dolle P., Koenig M. Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum. Mol. Genet. 2000, 9:1219-1226.
196. Busi M.V., Maliandi M.V., Valdez H., Clemente M., Zabaleta E.J., Araya A., Gomez-Casati D.F. Deficiency of Arabidopsis thaliana frataxin alters activity of mitochondrial Fe-S proteins and induces oxidative stress. Plant J. 2006, 48:873-882.
197. Ventura N., Rea S.L., Testi R. Long-lived C. elegans mitochondrial mutants as a model for human mitochondrial-associated diseases. Exp. Gerontol. 2006, 41:974-991.
198. Xia H., Cao Y., Dai X., Marelja Z., Zhou D., Mo R., Al-Mahdawi S., Pook M.A., Leimkuhler S., Rouault T.A., Li K. Novel frataxin isoforms may contribute to the pathological mechanism of Friedreich ataxia. PLoS One 2012, 7:e47847.
199. Koutnikova H., Campuzano V., Foury F., Dolle P., Cazzalini O., Koenig M. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat. Genet. 1997, 16:345-351.
200. Montermini L., Andermann E., Labuda M., Richter A., Pandolfo M., Cavalcanti F., Pianese L., Iodice L., Farina G., Monticelli A., Turano M., Filla A., De Michele G., Cocozza S. The Friedreich ataxia GAA triplet repeat: premutation and normal alleles. Hum. Mol. Genet. 1997, 6:1261-1266.
201. Puccio H., Simon D., Cossee M., Criqui-Filipe P., Tiziano F., Melki J., Hindelang C., Matyas R., Rustin P., Koenig M. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat. Genet. 2001, 27:181-186.
202. Frugier T., Tiziano F.D., Cifuentes-Diaz C., Miniou P., Roblot N., Dierich A., Le Meur M., Melki J. Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy. Hum. Mol. Genet. 2000, 9:849-858.
203. Simon D., Seznec H., Gansmuller A., Carelle N., Weber P., Metzger D., Rustin P., Koenig M., Puccio H. Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia. J. Neurosci. 2004, 24:1987-1995.
204. Ristow M., Mulder H., Pomplun D., Schulz T.J., Muller-Schmehl K., Krause A., Fex M., Puccio H., Muller J., Isken F., Spranger J., Muller-Wieland D., Magnuson M.A., Mohlig M., Koenig M., Pfeiffer A.F. Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass. J. Clin. Invest. 2003, 112:527-534.
205. Miranda C.J., Santos M.M., Ohshima K., Smith J., Li L., Bunting M., Cossee M., Koenig M., Sequeiros J., Kaplan J., Pandolfo M. Frataxin knockin mouse. FEBS Lett. 2002, 512:291-297.
206. Pook M.A., Al-Mahdawi S., Carroll C.J., Cossee M., Puccio H., Lawrence L., Clark P., Lowrie M.B., Bradley J.L., Cooper J.M., Koenig M., Chamberlain S. Rescue of the Friedreich's ataxia knockout mouse by human YAC transgenesis. Neurogenetics 2001, 3:185-193.
207. Sturm B., Bistrich U., Schranzhofer M., Sarsero J.P., Rauen U., Scheiber-Mojdehkar B., de Groot H., Ioannou P., Petrat F. Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity?. J. Biol. Chem. 2005, 280:6701-6708.
208. Jauslin M.L., Meier T., Smith R.A., Murphy M.P. Mitochondria-targeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J. 2003, 17:1972-1974.
209. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
210. Li K., Besse E.K., Ha D., Kovtunovych G., Rouault T.A. Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia. Hum. Mol. Genet. 2008, 17:2265-2273.
211. Huang M.L., Becker E.M., Whitnall M., Suryo Rahmanto Y., Ponka P., Richardson D.R. Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:16381-16386.
212. Seznec H., Simon D., Bouton C., Reutenauer L., Hertzog A., Golik P., Procaccio V., Patel M., Drapier J.C., Koenig M., Puccio H. Friedreich ataxia: the oxidative stress paradox. Hum. Mol. Genet. 2005, 14:463-474.
213. Armstrong J.S., Khdour O., Hecht S.M. Does oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question. FASEB J. 2010, 24:2152-2163.
214. Perdomini M., Hick A., Puccio H., Pook M.A. Animal and cellular models of Friedreich ataxia. J. Neurochem. 2013, 126(Suppl. 1):65-79.
215. Perdomini M., Belbellaa B., Monassier L., Reutenauer L., Messaddeq N., Cartier N., Crystal R.G., Aubourg P., Puccio H. Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia. Nat. Med. 2014, 20:542-547.
216. Farhan S.M., Wang J., Robinson J.F., Lahiry P., Siu V.M., Prasad C., Kronick J.B., Ramsay D.A., Rupar C.A., Hegele R.A. Exome sequencing identifies NFS1 deficiency in a novel Fe-S cluster disease, infantile mitochondrial complex II/III deficiency. Mol. Genet. Genomics Med. 2014, 2:73-80.
217. Marelja Z., Stocklein W., Nimtz M., Leimkuhler S. A novel role for human Nfs1 in the cytoplasm: Nfs1 acts as a sulfur donor for MOCS3, a protein involved in molybdenum cofactor biosynthesis. J. Biol. Chem. 2008, 283:25178-25185.
218. Mendel R.R. The molybdenum cofactor. J. Biol. Chem. 2013, 288:13165-13172.
219. Shigi N. Biosynthesis and functions of sulfur modifications in tRNA. Front. Genet. 2014, 5:67.
220. Biederbick A., Stehling O., Rosser R., Niggemeyer B., Nakai Y., Elsasser H.P., Lill R. Role of human mitochondrial Nfs1 in cytosolic iron-sulfur protein biogenesis and iron regulation. Mol. Cell. Biol. 2006, 26:5675-5687.
221. Fosset C., Chauveau M.J., Guillon B., Canal F., Drapier J.C., Bouton C. RNA silencing of mitochondrial m-Nfs1 reduces Fe-S enzyme activity both in mitochondria and cytosol of mammalian cells. J. Biol. Chem. 2006, 281:25398-25406.
222. Larsson L.E., Linderholm H., Mueller R., Ringqvist T., Soernaes R. Hereditary metabolic myopathy with paroxysmal myoglobinuria due to abnormal glycolysis. J. Neurol. Neurosurg. Psychiatry 1964, 27:361-380.
223. Linderholm H., Muller R., Ringqvist T., Sornas R. Hereditary abnormal muscle metabolism with hyperkinetic circulation during exercise. Acta Med. Scand. 1969, 185:153-166.
224. Kollberg G., Melberg A., Holme E., Oldfors A. Transient restoration of succinate dehydrogenase activity after rhabdomyolysis in iron-sulphur cluster deficiency myopathy. Neuromuscul. Disord. 2011, 21:115-120.
225. Drugge U., Holmberg M., Holmgren G., Almay B.G., Linderholm H. Hereditary myopathy with lactic acidosis, succinate dehydrogenase and aconitase deficiency in northern Sweden: a genealogical study. J. Med. Genet. 1995, 32:344-347.
226. Linderholm H., Essen-Gustavsson B., Thornell L.E. Low succinate dehydrogenase (SDH) activity in a patient with a hereditary myopathy with paroxysmal myoglobinuria. J. Intern. Med. 1990, 228:43-52.
227. Mochel F., Knight M.A., Tong W.H., Hernandez D., Ayyad K., Taivassalo T., Andersen P.M., Singleton A., Rouault T.A., Fischbeck K.H., Haller R.G. Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes myopathy with exercise intolerance. Am. J. Hum. Genet. 2008, 82:652-660.
228. Haller R.G., Henriksson K.G., Jorfeldt L., Hultman E., Wibom R., Sahlin K., Areskog N.H., Gunder M., Ayyad K., Blomqvist C.G., et al. Deficiency of skeletal muscle succinate dehydrogenase and aconitase. Pathophysiology of exercise in a novel human muscle oxidative defect. J. Clin. Invest. 1991, 88:1197-1206.
229. Olsson A., Lind L., Thornell L.E., Holmberg M. Myopathy with lactic acidosis is linked to chromosome 12q23.3-24.11 and caused by an intron mutation in the ISCU gene resulting in a splicing defect. Hum. Mol. Genet. 2008, 17:1666-1672.
230. Crooks D.R., Jeong S.Y., Tong W.H., Ghosh M.C., Olivierre H., Haller R.G., Rouault T.A. Tissue specificity of a human mitochondrial disease: differentiation-enhanced mis-splicing of the Fe-S scaffold gene ISCU renders patient cells more sensitive to oxidative stress in ISCU myopathy. J. Biol. Chem. 2012, 287:40119-40130.
231. Kollberg G., Tulinius M., Melberg A., Darin N., Andersen O., Holmgren D., Oldfors A., Holme E. Clinical manifestation and a new ISCU mutation in iron-sulphur cluster deficiency myopathy. Brain 2009, 132:2170-2179.
232. Saha P.P., Kumar S.K., Srivastava S., Sinha D., Pareek G., D'Silva P. The presence of multiple cellular defects associated with a novel G50E iron-sulfur cluster scaffold protein (ISCU) mutation leads to development of mitochondrial myopathy. J. Biol. Chem. 2014, 289:10359-10377.
233. Crooks D.R., Natarajan T.G., Jeong S.Y., Chen C., Park S.Y., Huang H., Ghosh M.C., Tong W.H., Haller R.G., Wu C., Rouault T.A. Elevated FGF21 secretion, PGC-1alpha and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscle. Hum. Mol. Genet. 2014, 23:24-39.
234. Nordin A., Larsson E., Holmberg M. The defective splicing caused by the ISCU intron mutation in patients with myopathy with lactic acidosis is repressed by PTBP1 but can be derepressed by IGF2BP1. Hum. Mutat. 2012, 33:467-470.
235. Kollberg G., Holme E. Antisense oligonucleotide therapeutics for iron-sulphur cluster deficiency myopathy. Neuromuscul. Disord. 2009, 19:833-836.
236. Sanaker P.S., Toompuu M., McClorey G., Bindoff L.A. Antisense oligonucleotide corrects splice abnormality in hereditary myopathy with lactic acidosis. Gene 2012, 494:231-236.
237. Kirby D.M., Crawford M., Cleary M.A., Dahl H.H., Dennett X., Thorburn D.R. Respiratory chain complex I deficiency: an underdiagnosed energy generation disorder. Neurology 1999, 52:1255-1264.
238. Sazanov L.A., Hinchliffe P. Structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus. Science 2006, 311:1430-1436.
239. Efremov R.G., Baradaran R., Sazanov L.A. The architecture of respiratory complex I. Nature 2010, 465:441-445.
240. Hunte C., Zickermann V., Brandt U. Functional modules and structural basis of conformational coupling in mitochondrial complex I. Science 2010, 329:448-451.
241. Baradaran R., Berrisford J.M., Minhas G.S., Sazanov L.A. Crystal structure of the entire respiratory complex I. Nature 2013, 494:443-448.
242. Efremov R.G., Sazanov L.A. Structure of the membrane domain of respiratory complex I. Nature 2011, 476:414-420.
243. Carroll J., Fearnley I.M., Shannon R.J., Hirst J., Walker J.E. Analysis of the subunit composition of complex I from bovine heart mitochondria. Mol. Cell. Proteomics 2003, 2:117-126.
244. McKenzie M., Ryan M.T. Assembly factors of human mitochondrial complex I and their defects in disease. IUBMB Life 2010, 62:497-502.
245. Ghezzi D., Zeviani M. Assembly factors of human mitochondrial respiratory chain complexes: physiology and pathophysiology. Adv. Exp. Med. Biol. 2012, 748:65-106.
246. Pagniez-Mammeri H., Rak M., Legrand A., Benit P., Rustin P., Slama A. Mitochondrial complex I deficiency of nuclear origin II. Non-structural genes. Mol. Genet. Metab. 2012, 105:173-179.
247. Wydro M.M., Balk J. Insights into the pathogenic character of a common NUBPL branch-site mutation associated with mitochondrial disease and complex I deficiency using a yeast model. Dis. Model. Mech. 2013, 6:1279-1284.
248. Tucker E.J., Mimaki M., Compton A.G., McKenzie M., Ryan M.T., Thorburn D.R. Next-generation sequencing in molecular diagnosis: NUBPL mutations highlight the challenges of variant detection and interpretation. Hum. Mutat. 2012, 33:411-418.
249. Tenisch E.V., Lebre A.S., Grevent D., de Lonlay P., Rio M., Zilbovicius M., Funalot B., Desguerre I., Brunelle F., Rotig A., Munnich A., Boddaert N. Massive and exclusive pontocerebellar damage in mitochondrial disease and NUBPL mutations. Neurology 2012, 79:391.
250. Kevelam S.H., Rodenburg R.J., Wolf N.I., Ferreira P., Lunsing R.J., Nijtmans L.G., Mitchell A., Arroyo H.A., Rating D., Vanderver A., van Berkel C.G., Abbink T.E., Heutink P., van der Knaap M.S. NUBPL mutations in patients with complex I deficiency and a distinct MRI pattern. Neurology 2013, 80:1577-1583.
251. Spiegel R., Saada A., Halvardson J., Soiferman D., Shaag A., Edvardson S., Horovitz Y., Khayat M., Shalev S.A., Feuk L., Elpeleg O. Deleterious mutation in FDX1L gene is associated with a novel mitochondrial muscle myopathy. Eur. J. Hum. Genet: EJHG 2014, 22:902-906.
252. Mayr J.A., Feichtinger R.G., Tort F., Ribes A., Sperl W. Lipoic acid biosynthesis defects. J. Inherit. Metab. Dis. 2014, 37:553-563.
253. Hiltunen J.K., Autio K.J., Schonauer M.S., Kursu V.A., Dieckmann C.L., Kastaniotis A.J. Mitochondrial fatty acid synthesis and respiration. Biochim. Biophys. Acta 2010, 1797:1195-1202.
254. Schonauer M.S., Kastaniotis A.J., Kursu V.A., Hiltunen J.K., Dieckmann C.L. Lipoic acid synthesis and attachment in yeast mitochondria. J. Biol. Chem. 2009, 284:23234-23242.
255. Morikawa T., Yasuno R., Wada H. Do mammalian cells synthesize lipoic acid? Identification of a mouse cDNA encoding a lipoic acid synthase located in mitochondria. FEBS Lett. 2001, 498:16-21.
256. Baker P.R., Friederich M.W., Swanson M.A., Shaikh T., Bhattacharya K., Scharer G.H., Aicher J., Creadon-Swindell G., Geiger E., MacLean K.N., Lee W.T., Deshpande C., Freckmann M.L., Shih L.Y., Wasserstein M., Rasmussen M.B., Lund A.M., Procopis P., Cameron J.M., Robinson B.H., Brown G.K., Brown R.M., Compton A.G., Dieckmann C.L., Collard R., Coughlin C.R., Spector E., Wempe M.F., Van Hove J.L. Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5. Brain 2014, 137:366-379.
257. Seyda A., Newbold R.F., Hudson T.J., Verner A., MacKay N., Winter S., Feigenbaum A., Malaney S., Gonzalez-Halphen D., Cuthbert A.P., Robinson B.H. A novel syndrome affecting multiple mitochondrial functions, located by microcell-mediated transfer to chromosome 2p14-2p13. Am. J. Hum. Genet. 2001, 68:386-396.
258. Harigae H., Furuyama K. Hereditary sideroblastic anemia: pathophysiology and gene mutations. Int. J. Hematol. 2010, 92:425-431.
259. Fujiwara T., Harigae H. Pathophysiology and genetic mutations in congenital sideroblastic anemia. Pediatr. Int. 2013, 55:675-679.
260. Harigae H., Suwabe N., Weinstock P.H., Nagai M., Fujita H., Yamamoto M., Sassa S. Deficient heme and globin synthesis in embryonic stem cells lacking the erythroid-specific delta-aminolevulinate synthase gene. Blood 1998, 91:798-805.
261. Camaschella C. Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment. Semin. Hematol. 2009, 46:371-377.
262. Guernsey D.L., Jiang H., Campagna D.R., Evans S.C., Ferguson M., Kellogg M.D., Lachance M., Matsuoka M., Nightingale M., Rideout A., Saint-Amant L., Schmidt P.J., Orr A., Bottomley S.S., Fleming M.D., Ludman M., Dyack S., Fernandez C.V., Samuels M.E. Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia. Nat. Genet. 2009, 41:651-653.
263. Pondarre C., Campagna D.R., Antiochos B., Sikorski L., Mulhern H., Fleming M.D. Abcb7, the gene responsible for X-linked sideroblastic anemia with ataxia, is essential for hematopoiesis. Blood 2007, 109:3567-3569.
264. Neufeld E.J., Fleming J.C., Tartaglini E., Steinkamp M.P. Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport. Blood Cells Mol. Dis. 2001, 27:135-138.
265. Fernandez-Vizarra E., Berardinelli A., Valente L., Tiranti V., Zeviani M. Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA). J. Med. Genet. 2007, 44:173-180.
266. Riley L.G., Cooper S., Hickey P., Rudinger-Thirion J., McKenzie M., Compton A., Lim S.C., Thorburn D., Ryan M.T., Giege R., Bahlo M., Christodoulou J. Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia-MLASA syndrome. Am. J. Hum. Genet. 2010, 87:52-59.
267. Ermanoska B., Motley W.W., Leitao-Goncalves R., Asselbergh B., Lee L.H., De Rijk P., Sleegers K., Ooms T., Godenschwege T.A., Timmerman V., Fischbeck K.H., Jordanova A. CMT-associated mutations in glycyl- and tyrosyl-tRNA synthetases exhibit similar pattern of toxicity and share common genetic modifiers in Drosophila. Neurobiol. Dis. 2014, 68C:180-189.
268. Crooks D.R., Ghosh M.C., Haller R.G., Tong W.H., Rouault T.A. Posttranslational stability of the heme biosynthetic enzyme ferrochelatase is dependent on iron availability and intact iron-sulfur cluster assembly machinery. Blood 2010, 115:860-869.
269. Eisenstein R.S. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu. Rev. Nutr. 2000, 20:627-662.
270. Pantopoulos K. Iron metabolism and the IRE/IRP regulatory system: an update. Ann. N. Y. Acad. Sci. 2004, 1012:1-13.
271. Applegarth D.A., Toone J.R. Glycine encephalopathy (nonketotic hyperglycinemia): comments and speculations. Am. J. Med. Genet. A 2006, 140:186-188.
272. Savary S., Allikmets R., Denizot F., Luciani M.F., Mattei M.G., Dean M., Chimini G. Isolation and chromosomal mapping of a novel ATP-binding cassette transporter conserved in mouse and human. Genomics 1997, 41:275-278.
273. Allikmets R., Raskind W.H., Hutchinson A., Schueck N.D., Dean M., Koeller D.M. Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum. Mol. Genet. 1999, 8:743-749.
274. Bekri S., Kispal G., Lange H., Fitzsimons E., Tolmie J., Lill R., Bishop D.F. Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation. Blood 2000, 96:3256-3264.
275. Maguire A., Hellier K., Hammans S., May A. X-linked cerebellar ataxia and sideroblastic anaemia associated with a missense mutation in the ABC7 gene predicting V411L. Br. J. Haematol. 2001, 115:910-917.
276. Boultwood J., Pellagatti A., Nikpour M., Pushkaran B., Fidler C., Cattan H., Littlewood T.J., Malcovati L., Della Porta M.G., Jadersten M., Killick S., Giagounidis A., Bowen D., Hellstrom-Lindberg E., Cazzola M., Wainscoat J.S. The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. PLoS One 2008, 3:e1970.
277. Nikpour M., Scharenberg C., Liu A., Conte S., Karimi M., Mortera-Blanco T., Giai V., Fernandez-Mercado M., Papaemmanuil E., Hogstrand K., Jansson M., Vedin I., Stephen Wainscoat J., Campbell P., Cazzola M., Boultwood J., Grandien A., Hellstrom-Lindberg E. The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts. Leukemia 2013, 27:889-896.
278. Paulsson K., Haferlach C., Fonatsch C., Hagemeijer A., Andersen M.K., Slovak M.L., Johansson B. The idic(X)(q13) in myeloid malignancies: breakpoint clustering in segmental duplications and association with TET2 mutations. Hum. Mol. Genet. 2010, 19:1507-1514.
279. Napier I., Ponka P., Richardson D.R. Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 2005, 105:1867-1874.
280. Pondarre C., Antiochos B.B., Campagna D.R., Clarke S.L., Greer E.L., Deck K.M., McDonald A., Han A.P., Medlock A., Kutok J.L., Anderson S.A., Eisenstein R.S., Fleming M.D. The mitochondrial ATP-binding cassette transporter Abcb7 is essential in mice and participates in cytosolic iron-sulfur cluster biogenesis. Hum. Mol. Genet. 2006, 15:953-964.
281. Srinivasan V., Pierik A.J., Lill R. Crystal structures of nucleotide-free and glutathione-bound mitochondrial ABC transporter Atm1. Science 2014, 343:1137-1140.
282. Leighton J., Schatz G. An ABC transporter in the mitochondrial inner membrane is required for normal growth of yeast. EMBO J. 1995, 14:188-195.
283. Sipos K., Lange H., Fekete Z., Ullmann P., Lill R., Kispal G. Maturation of cytosolic iron-sulfur proteins requires glutathione. J. Biol. Chem. 2002, 277:26944-26949.
284. Kumar C., Igbaria A., D'Autreaux B., Planson A.G., Junot C., Godat E., Bachhawat A.K., Delaunay-Moisan A., Toledano M.B. Glutathione revisited: a vital function in iron metabolism and ancillary role in thiol-redox control. EMBO J. 2011, 30:2044-2056.
285. Bernard D.G., Cheng Y., Zhao Y., Balk J. An allelic mutant series of ATM3 reveals its key role in the biogenesis of cytosolic iron-sulfur proteins in Arabidopsis. Plant Physiol. 2009, 151:590-602.
286. Kispal G., Csere P., Guiard B., Lill R. The ABC transporter Atm1p is required for mitochondrial iron homeostasis. FEBS Lett. 1997, 418:346-350.
287. Bedekovics T., Li H., Gajdos G.B., Isaya G. Leucine biosynthesis regulates cytoplasmic iron-sulfur enzyme biogenesis in an Atm1p-independent manner. J. Biol. Chem. 2011, 286:40878-40888.
288. Young L., Leonhard K., Tatsuta T., Trowsdale J., Langer T. Role of the ABC transporter Mdl1 in peptide export from mitochondria. Science 2001, 291:2135-2138.
289. Chloupkova M., LeBard L.S., Koeller D.M. MDL1 is a high copy suppressor of ATM1: evidence for a role in resistance to oxidative stress. J. Mol. Biol. 2003, 331:155-165.
290. Rees D.C., Johnson E., Lewinson O. ABC transporters: the power to change. Nat. Rev. Mol. Cell Biol. 2009, 10:218-227.
291. Chen S., Sanchez-Fernandez R., Lyver E.R., Dancis A., Rea P.A. Functional characterization of AtATM1, AtATM2, and AtATM3, a subfamily of Arabidopsis half-molecule ATP-binding cassette transporters implicated in iron homeostasis. J. Biol. Chem. 2007, 282:21561-21571.
292. Teschner J., Lachmann N., Schulze J., Geisler M., Selbach K., Santamaria-Araujo J., Balk J., Mendel R.R., Bittner F. A novel role for Arabidopsis mitochondrial ABC transporter ATM3 in molybdenum cofactor biosynthesis. Plant Cell 2010, 22:468-480.
293. Kuhnke G., Neumann K., Muhlenhoff U., Lill R. Stimulation of the ATPase activity of the yeast mitochondrial ABC transporter Atm1p by thiol compounds. Mol. Membr. Biol. 2006, 23:173-184.
294. D'Hooghe M., Selleslag D., Mortier G., Van Coster R., Vermeersch P., Billiet J., Bekri S. X-linked sideroblastic anemia and ataxia: a new family with identification of a fourth ABCB7 gene mutation. Eur. J. Paediatr. Neurol. 2012, 16:730-735.
295. Todd D.J. Erythropoietic protoporphyria. Br. J. Dermatol. 1994, 131:751-766.
296. Lecha M., Puy H., Deybach J.C. Erythropoietic protoporphyria. Orphanet. J. Rare Dis. 2009, 4:19.
297. Pagano M.B., Hobbs W., Linenberger M., Delaney M. Plasma and red cell exchange transfusions for erythropoietic protoporphyria: a case report and review of the literature. J. Clin. Apher. 2012, 27:336-341.
298. Bloomer J.R., Phillips M.J., Davidson D.L., Klatskin G. Hepatic disease in erythropoietic protoporphyria. Am. J. Med. 1975, 58:869-882.
299. Bonkowsky H.L., Bloomer J.R., Ebert P.S., Mahoney M.J. Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts. J. Clin. Invest. 1975, 56:1139-1148.
300. Ohgari Y., Sawamoto M., Yamamoto M., Kohno H., Taketani S. Ferrochelatase consisting of wild-type and mutated subunits from patients with a dominant-inherited disease, erythropoietic protoporphyria, is an active but unstable dimer. Hum. Mol. Genet. 2005, 14:327-334.
301. Herrero C., To-Figueras J., Badenas C., Mendez M., Serrano P., Enriquez-Salamanca R., Lecha M. Clinical, biochemical, and genetic study of 11 patients with erythropoietic protoporphyria including one with homozygous disease. Arch. Dermatol. 2007, 143:1125-1129.
302. Shaw G.C., Cope J.J., Li L., Corson K., Hersey C., Ackermann G.E., Gwynn B., Lambert A.J., Wingert R.A., Traver D., Trede N.S., Barut B.A., Zhou Y., Minet E., Donovan A., Brownlie A., Balzan R., Weiss M.J., Peters L.L., Kaplan J., Zon L.I., Paw B.H. Mitoferrin is essential for erythroid iron assimilation. Nature 2006, 440:96-100.
303. Paradkar P.N., Zumbrennen K.B., Paw B.H., Ward D.M., Kaplan J. Regulation of mitochondrial iron import through differential turnover of mitoferrin 1 and mitoferrin 2. Mol. Cell. Biol. 2009, 29:1007-1016.
304. Foury F., Roganti T. Deletion of the mitochondrial carrier genes MRS3 and MRS4 suppresses mitochondrial iron accumulation in a yeast frataxin-deficient strain. J. Biol. Chem. 2002, 277:24475-24483.
305. Zhang Y., Lyver E.R., Knight S.A., Lesuisse E., Dancis A. Frataxin and mitochondrial carrier proteins, Mrs3p and Mrs4p, cooperate in providing iron for heme synthesis. J. Biol. Chem. 2005, 280:19794-19807.
306. Muhlenhoff U., Stadler J.A., Richhardt N., Seubert A., Eickhorst T., Schweyen R.J., Lill R., Wiesenberger G. A specific role of the yeast mitochondrial carriers MRS3/4p in mitochondrial iron acquisition under iron-limiting conditions. J. Biol. Chem. 2003, 278:40612-40620.
307. Chen W., Dailey H.A., Paw B.H. Ferrochelatase forms an oligomeric complex with mitoferrin-1 and Abcb10 for erythroid heme biosynthesis. Blood 2010, 116:628-630.
308. Wu C.K., Dailey H.A., Rose J.P., Burden A., Sellers V.M., Wang B.C. The 2.0 A structure of human ferrochelatase, the terminal enzyme of heme biosynthesis. Nat. Struct. Biol. 2001, 8:156-160.
309. Wang Y., Langer N.B., Shaw G.C., Yang G., Li L., Kaplan J., Paw B.H., Bloomer J.R. Abnormal mitoferrin-1 expression in patients with erythropoietic protoporphyria. Exp. Hematol. 2011, 39:784-794.
310. Chung J., Anderson S.A., Gwynn B., Deck K.M., Chen M.J., Langer N.B., Shaw G.C., Huston N.C., Boyer L.F., Datta S., Paradkar P.N., Li L., Wei Z., Lambert A.J., Sahr K., Wittig J.G., Chen W., Lu W., Galy B., Schlaeger T.M., Hentze M.W., Ward D.M., Kaplan J., Eisenstein R.S., Peters L.L., Paw B.H. Iron regulatory protein-1 protects against mitoferrin-1-deficient porphyria. J. Biol. Chem. 2014, 289:7835-7843.
311. Isaya G. Mitochondrial iron-sulfur cluster dysfunction in neurodegenerative disease. Front. Pharmacol. 2014, 5:29.
312. Kaplan J., McVey Ward D., Crisp R.J., Philpott C.C. Iron-dependent metabolic remodeling in S. cerevisiae. Biochim. Biophys. Acta 2006, 1763:646-651.
313. Li J., Kogan M., Knight S.A., Pain D., Dancis A. Yeast mitochondrial protein, Nfs1p, coordinately regulates iron-sulfur cluster proteins, cellular iron uptake, and iron distribution. J. Biol. Chem. 1999, 274:33025-33034.
314. Babcock M., de Silva D., Oaks R., Davis-Kaplan S., Jiralerspong S., Montermini L., Pandolfo M., Kaplan J. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 1997, 276:1709-1712.
315. Garland S.A., Hoff K., Vickery L.E., Culotta V.C. Saccharomyces cerevisiae ISU1 and ISU2: members of a well-conserved gene family for iron-sulfur cluster assembly. J. Mol. Biol. 1999, 294:897-907.
316. Schilke B., Voisine C., Beinert H., Craig E. Evidence for a conserved system for iron metabolism in the mitochondria of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10206-10211.
317. Knight S.A., Sepuri N.B., Pain D., Dancis A. Mt-Hsp70 homolog, Ssc2p, required for maturation of yeast frataxin and mitochondrial iron homeostasis. J. Biol. Chem. 1998, 273:18389-18393.
318. Lange H., Kaut A., Kispal G., Lill R. A mitochondrial ferredoxin is essential for biogenesis of cellular iron-sulfur proteins. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:1050-1055.
319. Rouault T.A., Tong W.H. Iron-sulphur cluster biogenesis and mitochondrial iron homeostasis. Nat. Rev. Mol. Cell Biol. 2005, 6:345-351.
320. Miao R., Kim H., Koppolu U.M., Ellis E.A., Scott R.A., Lindahl P.A. Biophysical characterization of the iron in mitochondria from Atm1p-depleted Saccharomyces cerevisiae. Biochemistry 2009, 48:9556-9568.
321. Lesuisse E., Santos R., Matzanke B.F., Knight S.A., Camadro J.M., Dancis A. Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1). Hum. Mol. Genet. 2003, 12:879-889.
322. Chen O.S., Crisp R.J., Valachovic M., Bard M., Winge D.R., Kaplan J. Transcription of the yeast iron regulon does not respond directly to iron but rather to iron-sulfur cluster biosynthesis. J. Biol. Chem. 2004, 279:29513-29518.
323. Rutherford J.C., Ojeda L., Balk J., Muhlenhoff U., Lill R., Winge D.R. Activation of the iron regulon by the yeast Aft1/Aft2 transcription factors depends on mitochondrial but not cytosolic iron-sulfur protein biogenesis. J. Biol. Chem. 2005, 280:10135-10140.
324. Koeppen A.H. Friedreich's ataxia: pathology, pathogenesis, and molecular genetics. J. Neurol. Sci. 2011, 303:1-12.
325. Foury F., Talibi D. Mitochondrial control of iron homeostasis. A genome wide analysis of gene expression in a yeast frataxin-deficient strain. J. Biol. Chem. 2001, 276:7762-7768.
326. Haynes C.M., Yang Y., Blais S.P., Neubert T.A., Ron D. The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans. Mol. Cell 2010, 37:529-540.
327. Zhao Q., Wang J., Levichkin I.V., Stasinopoulos S., Ryan M.T., Hoogenraad N.J. A mitochondrial specific stress response in mammalian cells. EMBO J. 2002, 21:4411-4419.
328. Yoneda T., Benedetti C., Urano F., Clark S.G., Harding H.P., Ron D. Compartment-specific perturbation of protein handling activates genes encoding mitochondrial chaperones. J. Cell Sci. 2004, 117:4055-4066.
329. Parkinson M.H., Boesch S., Nachbauer W., Mariotti C., Giunti P. Clinical features of Friedreich's ataxia: classical and atypical phenotypes. J. Neurochem. 2013, 126(Suppl 1):103-117.
330. Puccio H., Anheim M., Tranchant C. Pathophysiogical and therapeutic progress in Friedreich ataxia. Rev. Neurol. 2014, 170:355-365.